Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component

Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component2018-01-17T17:00:25-05:00

Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component

Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component2018-01-17T17:00:25-05:00

Pathogenesis of multiple sclerosis: an update on immunology

Pathogenesis of multiple sclerosis: an update on immunology2018-01-17T17:00:25-05:00

Yin–Yang regulation of autoimmunity by DCs

Yin–Yang regulation of autoimmunity by DCs2018-01-17T17:00:25-05:00

Estimates of optimal vitamin D status

Estimates of optimal vitamin D status2018-01-17T17:00:25-05:00

Polyphenols: antioxidants and beyond

Polyphenols: antioxidants and beyond2018-01-17T17:00:21-05:00

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre2018-01-17T17:00:21-05:00

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation2018-01-17T17:00:21-05:00

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis2018-01-17T17:00:21-05:00

Sunscreens and melanoma: the future looks bright

Sunscreens and melanoma: the future looks bright2018-01-17T17:00:21-05:00